Publication ethics and publication malpractice statement
The Acta Biologica Marisiensis (ABM) is an Open Access journal. All articles are available free in both print (ISSN: 2601 – 6141) and electronic (ISSN-L: 2601 – 6141) form for a non-commercial purpose.
The journal does not have article processing charges, neither article submission charges.
Therefore, authors are asked to indicate their agreement to abide by an open-access license. The license permits any user to download, print out, extract, archive, and distribute the article, so long as appropriate credit is given to the authors and source of the work. The license ensures that your article will be as widely available as possible and that your article can be included in any scientific archive.
The editors assume that all author(s) listed in a manuscript have agreed with the following policy of the ABM on its submission. If an author(s) should be added or deleted after submission of the manuscript, it is the responsibility of the corresponding author to ensure that the author(s) involved are aware of and agree to the change in the authorship. The ABM has no responsibility for such changes.
The articles submitted to ABM must be previously unpublished and not be under consideration for publication elsewhere. Reviewers will be asked to comment on the overlap between related submissions.
The ABM journal, reviews all the submitted manuscripts. Only manuscripts with positive referee reviews are acceptable for publication in ABM, in both print and electronic forms for non-commercial purposes.
All research studies involving human subjects must have received approval of the appropriate institutional ethics committee and informed consent must be obtained from all the patients participating in the studies, prior to manuscript submission.
In cases where the institutional ethics review committee ruled that approval from them was not required or that the need for informed consent was unnecessary, a statement from the committee to this end should be forwarded to the Editor with the manuscript.
Authorship, copyrights and declaration of interests:
Authors who publish with ABM agree to the following terms:
- The manuscript submitted represents our own original work and has not been published and is not being submitted or considered for publication elsewhere
- All authors have contributed to the manuscript and that common agreement has been reached before submission.
- All authors participated in the work in a substantive way and are prepared to take public responsibility for the work.
- The text, illustrations, and any other materials included in the manuscript do not infringe upon any existing copyright or other rights of anyone.
- The authors are agreeing that all materials submitted for evaluation (including text, figures, etc.) retains the property / copyrights of the journal Acta Biologica Marisiensis. In the case of papers that were not accepted for publication in the journal, after their rejection the property of all materials will backward to the authors.
- Reproduction, posting, transmission or other distribution or use of the article or any material contained therein, requires citation of the journal Acta Biologica Marisiensis.
- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Authors responsibilities:
The Journal Acta Biologica Marisiensis follows the International Committee of Medical Journal Editors guidelines which state that, in order to qualify for authorship of a manuscript, the following criteria should be observed:
- Substantial contributions to the conception or design of the work; or the acquisition, analysis or interpretation of data for the work;
- Drafting the work or revising it critically for important intellectual content;
- Provide approval for publication of the content;
- Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Contributors, who do not meet these criteria, but nonetheless provided important contributions to the final manuscript, should be included in the acknowledgements section.
The corresponding author takes primary responsibility for communication with the journal and editorial board during the submission process, throughout peer review and during publication. The corresponding author is also responsible for ensuring that the submission adheres to all journal requirements. The corresponding author should also be available post-publication to respond to any queries or critiques.
Human and animal rights:
All research studies involving human subjects must have received approval of the appropriate institutional ethics committee and informed consent must be obtained from all the patients participating in the studies, prior to manuscript submission.
In cases where the institutional ethics review committee ruled that approval from them was not required or that the need for informed consent was unnecessary, a statement from the committee to this end should be forwarded to the Editor with the manuscript.
Studies involving experimental research on animals or humans must conform to the guiding principles of the Declaration of Helsinki. In order to respect a patient`s right to privacy, identifying information such as patients` names, images, initials of hospital numbers should not be included in any published material (tables, figures, text), unless the information is essential for scientific content. In these cases written permission must be obtained from the patient, and should be submitted to the editorial office at the time of manuscript submission. In the case of animal experiments, both national and the institutional guidelines pertaining to the experimental use of laboratory animals should be rigidly followed.
Clinical trials:
In case of manuscripts presenting clinical trials, the clinical trial should be registered in a public trials registry at or before the time of first patient enrollment, as a condition for consideration for publication. Trials should be preferably registered in ClinicalTrials.gov, but any registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) is acceptable, in accordance with the guidelines of the International Committee of Medical Journal Editors.
Conflict of interest (Declaration of Interests):
The manuscript should contain a statement fully disclosing any conflict of interest related to the manuscript. If there are no conflicts of interest, this should be stated as “none declared”. Material and financial support should also be acknowledged.
Scientific misconduct:
Scientific misconduct includes data fabrication, falsification, plagiarism, redundant publication, ghost authorship or other fraudulent research practices. In order to prevent plagiarism issues, all manuscripts sent to the journal will be screened using anti-plagiarism soft-ware. Where there is a suspicion of scientific misconduct, the Editor will act in conformity with the principles stated in the COPE guidelines and if the fraudulent practice is confirmed the manuscript will be rejected outright and without the Editor entering into any further correspondence.